{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T17:47:08Z","timestamp":1763142428142,"version":"3.40.3"},"reference-count":10,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T00:00:00Z","timestamp":1741392000000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Internal Medicine Journal"],"published-print":{"date-parts":[[2025,3]]},"abstract":"Abstract<\/jats:title>Background<\/jats:title>Faecal calprotectin is a reliable biomarker for lower gastrointestinal inflammation. However, there are limited data on the utility of calprotectin from stoma effluent.<\/jats:p><\/jats:sec>Aim<\/jats:title>The aim of this study was to determine the performance of stomal calprotectin in identifying Crohn disease activity in those with a stoma.<\/jats:p><\/jats:sec>Methods<\/jats:title>Patients with Crohn disease and an ileostomy or colostomy were identified from three sites in Australia using a clinical management software. Disease activity was classified based on the presence of inflammation on imaging and\/or endoscopy within 3 months of the sample. The primary outcome was the median stomal calprotectin in people with active versus inactive Crohn disease. Other clinical indices, such as C\u2010reactive protein and Harvey Bradshaw Index, were evaluated as a surrogate biomarker for disease activity.<\/jats:p><\/jats:sec>Results<\/jats:title>Thirty stomal calprotectin results were identified for 23 patients with paired investigations. Of 30 cases, six had active disease. The median stomal calprotectin in active versus inactive disease were 17 \u03bcg\/g (interquartile range (IQR) 5\u2013211) and 61 \u03bcg\/g (IQR 19\u2013105, P<\/jats:italic> =\u20090.38) respectively. Accordingly, stomal calprotectin demonstrated poor sensitivity for active disease (33% at cut\u2010off of 50\u2009\u03bcg\/g). C\u2010reactive protein was higher for active disease (25, IQR 5\u2013199) compared with inactive disease (5, IQR 2\u201317, P<\/jats:italic> =\u20090.06), but there was no difference in the Harvey Bradshaw Index (9 (IQR 7\u201311) vs 5 (3\u20137), P<\/jats:italic> =\u20090.10).<\/jats:p><\/jats:sec>Conclusion<\/jats:title>Stomal calprotectin did not reliably distinguish between active and inactive Crohn disease. C\u2010reactive protein is a more reliable biomarker for disease activity in the setting of ileostomy\/colostomy. Further prospective studies are needed to identify more robust biomarkers for detecting inflammation in stoma patients.<\/jats:p><\/jats:sec>","DOI":"10.1111\/imj.16648","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T04:29:25Z","timestamp":1741753765000},"page":"461-466","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Stomal calprotectin as a biomarker for assessing Crohn\u00a0disease activity in patients with stomas"],"prefix":"10.1111","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-7177-1207","authenticated-orcid":false,"given":"Kavindra","family":"Abeyratne","sequence":"first","affiliation":[{"name":"Faculty of Health and Medical Sciences The University of Adelaide Adelaide South Australia Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6288-1788","authenticated-orcid":false,"given":"Martin","family":"Harb","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology Department Liverpool Hospital South West Sydney Clinical Campuses, University of NSW Sydney Sydney New South Wales Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Bensted","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology Department St Vincent's Hospital Sydney, St Vincent's Clinical School, UNSW Sydney Sydney New South Wales Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Ghaly","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology Department St Vincent's Hospital Sydney, St Vincent's Clinical School, UNSW Sydney Sydney New South Wales Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan J.","family":"Connor","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology Department Liverpool Hospital South West Sydney Clinical Campuses, University of NSW Sydney Sydney New South Wales Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane M.","family":"Andrews","sequence":"additional","affiliation":[{"name":"Faculty of Health and Medical Sciences The University of Adelaide Adelaide South Australia Australia"},{"name":"Gastroenterology and Hepatology Department Royal Adelaide Hospital Adelaide South Australia Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate D.","family":"Lynch","sequence":"additional","affiliation":[{"name":"Faculty of Health and Medical Sciences The University of Adelaide Adelaide South Australia Australia"},{"name":"Gastroenterology and Hepatology Department Royal Adelaide Hospital Adelaide South Australia Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,3,8]]},"reference":[{"key":"e_1_2_8_2_1","first-page":"303","article-title":"Crohn disease phenotype, prognosis, and long\u2010term complications: what to expect?","volume":"71","author":"Cosnes J","year":"2008","journal-title":"Acta Gastroenterol Belg"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000161030.25860.c1"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13886"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13356"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/bs.acc.2018.07.005"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000057"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1080\/00365521.2020.1839960"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjab182"},{"key":"e_1_2_8_10_1","article-title":"The accuracy of faecal calprotectin measurement from stoma effluent in predicting Crohn disease activity","volume":"67","author":"Bouri S","year":"2018","journal-title":"Gut"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(23)03056-1"}],"container-title":["Internal Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/imj.16648","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T02:55:09Z","timestamp":1743562509000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/imj.16648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10.1111\/imj.16648"],"URL":"https:\/\/doi.org\/10.1111\/imj.16648","archive":["Portico"],"relation":{},"ISSN":["1444-0903","1445-5994"],"issn-type":[{"type":"print","value":"1444-0903"},{"type":"electronic","value":"1445-5994"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"2024-06-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}